Development of diagnostic methods for toxoplasmosis and molecular phylogenetic analysis of Toxoplasma gondii

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030230328

Enrollment

520

Registered

2023-09-05

Start date

2023-08-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

toxoplasmosis Toxoplasma gondii, toxoplasmosis, congenital, acquired

Interventions

Toxoplasma DNA testing goes beyond the scope of normal medical treatment.

D014123

DNA test, PCR analysis

Eligibility

Inclusion criteria

Inclusion criteria: Patients who are suspected of having toxoplasmosis and have requested toxoplasmosis PCR diagnosis from medical facilities across the country will be asked to use the remaining samples/DNA after PCR diagnosis, and patients who have consented will be targeted. The age, gender, inpatient/outpatient status, detailed disease classification, pretreatment regulations, etc. of the target patient are not considered. (including minors)

Exclusion criteria

Exclusion criteria: Pretreatment regulations, medical past history, complications, laboratory test data, etc. of the target patients are not considered.

Design outcomes

Primary

Measure	Time frame
tokisoplasma antibody titer	—

Contacts

Public ContactKazumi Norose

Department of Medicine, Shinshu University

knorose@shinshu-u.ac.jp+81-263-37-2625

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026